---
document_datetime: 2024-10-17 09:28:59
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/ambrisentan-viatris-epar-all-authorised-presentations_en.pdf
document_name: ambrisentan-viatris-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.0646711
conversion_datetime: 2025-12-29 22:14:46.550534
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name     | Strength   | Pharmaceutical Form   | Route of Administration   | Immediate Packaging    | Pack size                  |
|------------------|---------------------|------------|-----------------------|---------------------------|------------------------|----------------------------|
| EU/1/19/1368/001 | Ambrisentan Viatris | 5 mg       | Film-coated tablet    | Oral use                  | blister (PVC/PVdC/alu) | 30 tablets                 |
| EU/1/19/1368/002 | Ambrisentan Viatris | 5 mg       | Film-coated tablet    | Oral use                  | blister (PVC/PVdC/alu) | 30 x 1 tablets (unit dose) |
| EU/1/19/1368/003 | Ambrisentan Viatris | 10 mg      | Film-coated tablet    | Oral use                  | blister (PVC/PVdC/alu) | 30 tablets                 |
| EU/1/19/1368/004 | Ambrisentan Viatris | 10 mg      | Film-coated tablet    | Oral use                  | blister (PVC/PVdC/alu) | 30 x 1 tablets (unit dose) |
| EU/1/19/1368/005 | Ambrisentan Viatris | 5 mg       | Film-coated tablet    | Oral use                  | blister (PVC/PVdC/alu) | 60 x 1 tablets (unit dose) |
| EU/1/19/1368/006 | Ambrisentan Viatris | 10 mg      | Film-coated tablet    | Oral use                  | blister (PVC/PVdC/alu) | 60 x 1 tablets (unit dose) |